Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Post-transcriptional control of Amblyomin-X on secretion of vascular endothelial growth factor and expression of adhesion molecules in endothelial cells

Full text
Author(s):
Drewes, C. C. [1] ; Dias, R. Y. [1] ; Branco, V. G. [2] ; Cavalcante, M. F. [3] ; Souza, J. G. [2] ; Abdalla, D. S. P. [3] ; Chudzinski-Tavassi, A. M. [2] ; Farsky, S. H. P. [1]
Total Authors: 8
Affiliation:
[1] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Analyses, Lab Expt Toxicol, BR-05503900 Sao Paulo, SP - Brazil
[2] Butantan Inst, Biochem & Biophys Lab, BR-05503900 Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Biochem Lab, BR-05503900 Sao Paulo, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Toxicon; v. 101, p. 1-10, JUL 2015.
Web of Science Citations: 7
Abstract

Angiogenesis is a pivotal process of homeostasis and tissue repair, but it also favours neovascularisation syndromes and cancer nutrition. The chemical mediation of angiogenesis is complex, involving a balance between serine proteases and their inhibitors. We addressed the mechanisms of action of a Kunitz serine protease inhibitor (KPI) on spontaneous angiogenesis, using Amblyomin-X, a KPI designed from the cDNA library of the Amblyomma cajennense tick. Amblyomin-X treatment (10-1000 ng/10 mu l.; each 48 h; 3 times) reduced the number of vessels in the subcutaneous dorsal tissue of male Swiss mice, as measured by intravital microscopy, haematoxylin-eosin staining, and PECAM-1 immunofluorescence labeling. Incubation of Amblyomin-X with t-End endothelial cells, a murine endothelial microvascular lineage, did not alter cell proliferation, cell-cycle phases, necrosis and apoptosis, and the production of nitric oxide and prostaglandin E2. Nevertheless, Amblyomin-X treatment reduced t-End migration and adhesion to Matrigel (R), and inhibited the VEGF-A secretion and VCAM-1 and beta(3) integrin expressions by posttranscriptional pathways. Together, data herein outline novel posttranscriptional mechanisms of KPIs on endothelial cells during angiogenesis and point out the possible application of Amblyomin-X as a local inhibitor to undesired neovascularisation process. (C) 2015 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 09/08584-6 - Supramolecular chemistry and nanotechnology
Grantee:Henrique Eisi Toma
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 13/07467-1 - CeTICS - Center of Toxins, Immune-Response and Cell Signaling
Grantee:Hugo Aguirre Armelin
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
FAPESP's process: 12/06944-8 - Effect of Amblyomin-X at interface of the immune system and hemostasis during progression RENCA tumor (murine renal cell carcinoma): in vivo and in vitro
Grantee:Jean Gabriel de Souza
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 10/19802-1 - Effects of lipid-core nanocapsules with acetyleugenol in melanomas: in vivo and in vitro studies
Grantee:Carine Cristiane Drewes
Support Opportunities: Scholarships in Brazil - Doctorate